A detailed history of Glen Eagle Advisors, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 796 shares of ARKG stock, worth $20,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares
796
Holding current value
$20,210
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$23.01 - $28.35 $529 - $652
23 Added 2.98%
796 $18.7 Million
Q1 2024

Jul 03, 2024

BUY
$27.9 - $32.96 $21,566 - $25,478
773 New
773 $22.2 Million
Q4 2023

Aug 13, 2024

BUY
$22.24 - $34.25 $6,049 - $9,316
272 Added 52.31%
792 $26 Million
Q2 2022

Aug 13, 2024

BUY
$27.2 - $48.94 $4,080 - $7,341
150 Added 40.54%
520 $16.4 Million
Q4 2021

Aug 13, 2024

BUY
$58.39 - $78.64 $1,051 - $1,415
18 Added 5.11%
370 $22.7 Million
Q1 2021

Aug 13, 2024

SELL
$81.74 - $112.47 $34,412 - $47,349
-421 Reduced 54.46%
352 $31.2 Million

Others Institutions Holding ARKG

About ARK GENOMIC REVOLUTION ETF (DE


  • Ticker ARKG
  • Sector ETFs
  • Industry ETFs
More about ARKG
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.